Relationship of urinary furosemide excretion rate to natriuretic effect in experimental azotemia
- PMID: 994014
Relationship of urinary furosemide excretion rate to natriuretic effect in experimental azotemia
Abstract
The relationship of natriuretic effect and furosemide excretion was studied in normal and azotemic dogs. Graded azotemia was produced in dogs by bilateral uretero-venous shunts of varying duration. The shunts were subsequently opened and urine and blood samples were taken to measure inulin, furosemide and sodium concentrations. Renal blood flow was measured by an electromagnetic flow probe. Two groups of dogs, control and experimental, were studied. The experimental group received a loading dose followed by a constant infusion of furosemide. This dose produced a natriuresis in nonazotemic normal dogs. The magnitude of this natriuresis correlated with furosemide excretion rate (P less than .005) and not with the plasma concentration of the drug. Furosemide clearance and extraction were inversely correlated with blood urea nitrogen. In the furosemide-treated group the augmentation of sodium excretion was not impaired except at blood urea nitrogen concentrations of greater than 200 mg/dl (two dogs). Thus the reduced clearance of furosemide may account in part for the high dose necessary. Further studies appear to be in order to clarify the relationship of the natriuretic response to furosemide to the rate of urinary excretion and plasma concentration of the drug.
Similar articles
-
Effect of experimental azotemia on renal clearance of furosemide in the dog.J Pharmacol Exp Ther. 1976 Jan;196(1):238-47. J Pharmacol Exp Ther. 1976. PMID: 1246013
-
Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.Circulation. 2004 Apr 6;109(13):1680-5. doi: 10.1161/01.CIR.0000124064.00494.21. Epub 2004 Mar 15. Circulation. 2004. PMID: 15023890
-
On the adaptation in sodium excretion in chronic uremia. The effects of "proportional reduction" of sodium intake.J Clin Invest. 1974 Jun;53(6):1736-41. doi: 10.1172/JCI107725. J Clin Invest. 1974. PMID: 4830234 Free PMC article.
-
Studies on the control of sodium excretion in experimental uremia.J Clin Invest. 1969 May;48(5):869-77. doi: 10.1172/JCI106045. J Clin Invest. 1969. PMID: 5780197 Free PMC article.
-
Regulation of renal sodium and water excretion in the nephrotic syndrome and cirrhosis of the liver.Dan Med Bull. 1997 Apr;44(2):191-207. Dan Med Bull. 1997. PMID: 9151012 Review.
Cited by
-
Kinetic disposition and diuretic effect of frusemide in acute pulmonary oedema.Br J Clin Pharmacol. 1980 May;9(5):471-8. doi: 10.1111/j.1365-2125.1980.tb05842.x. Br J Clin Pharmacol. 1980. PMID: 7397063 Free PMC article.
-
The pharmacokinetics of frusemide are influenced by age.Br J Clin Pharmacol. 1983 Oct;16(4):391-7. doi: 10.1111/j.1365-2125.1983.tb02183.x. Br J Clin Pharmacol. 1983. PMID: 6626433 Free PMC article.
-
Resistance to diuretics: emphasis on a pharmacological perspective.Drugs. 1981 Dec;22(6):477-94. doi: 10.2165/00003495-198122060-00004. Drugs. 1981. PMID: 7032875 Review.
-
The added-up albumin enhances the diuretic effect of furosemide in patients with hypoalbuminemic chronic kidney disease: a randomized controlled study.BMC Nephrol. 2012 Aug 29;13:92. doi: 10.1186/1471-2369-13-92. BMC Nephrol. 2012. PMID: 22931630 Free PMC article. Clinical Trial.
-
Clinical pharmacokinetics of frusemide.Clin Pharmacokinet. 1979 Jul-Aug;4(4):279-96. doi: 10.2165/00003088-197904040-00002. Clin Pharmacokinet. 1979. PMID: 385209 Review. No abstract available.